Questions and answers on Article 35 veterinary referral procedures
Submitted by Anonymous (not verified) on 14 December 2023 - 10:47
Questions and answers on Article 35 veterinary referral procedures
Notifying a change of marketing status and sunset clause (veterinary medicines)
Submitted by Anonymous (not verified) on 14 December 2023 - 10:33
Notifying a change of marketing status and sunset clause (veterinary medicines)
Maximum residue limits (MRL)
Submitted by Anonymous (not verified) on 14 December 2023 - 9:43
Maximum residue limits (MRL)
Marketing authorisation (veterinary medicines)
Submitted by Anonymous (not verified) on 14 December 2023 - 9:43
Marketing authorisation (veterinary medicines)
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 13 December 2023 - 14:10
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 5, Status: Authorised
European Medicines Agency’s privacy statement for the pre-employment medical examination
Submitted by Anonymous (not verified) on 13 December 2023 - 14:05
European Medicines Agency’s privacy statement for the pre-employment medical examination
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 13 December 2023 - 14:04
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 13 December 2023 - 14:04
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 13 December 2023 - 14:00
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 13 December 2023 - 14:00
List of medicinal products under additional monitoring